First-line treatment for primary<unk>  consists of anti-inflammatory drugs. Specifically, glucocorticoids are begun in patients manifesting with nephrotic-range proteinuria (>3.5 g/day). For patients who maintain nephrotic-range proteinuria despite glucocorticoids, or for patients who demonstrate glucocorticoid intolerance, calcineurin inhibitors (e.g., tacrolimus) are initiated. Successful treatment is defined as a drop in proteinuria to sub-nephrotic ranges. The treatment of secondary<unk>  involves addressing the particular toxic or stress agent.
Focal segmental glomerulosclerosis
Membranous glomerulonephritis
Minimal mesangial glomerulonephritis
Mesangial proliferative glomerulonephritis
Focal proliferative nephritis
IgA nephropathy
Mesoamerican nephropathy
Membranoproliferative glomerulonephritis